Pharmaceutical Drug Manufacturers

March 17, 2010- An emerging market research report published by IMS Health Inc. on Tuesday indicated a new order in the global pharmaceutical industry with the emerging markets of developing countries set to overtake some established national markets in pharmaceutical sales. About 50% of the growth of pharmaceutical industry is predicted to come from emerging markets by 2013. These emerging markets include names like China, Brazil, Russia, India, Venezuela, Argentina and the like.

The emerging markets report gave the name "pharmerging" markets to these high-growth areas. The report marks 17 countries as high-growth models. All these 17 emerging markets of pharma industry have been divided into three tiers.

China tops the list that has been predicted to become world's third-largest market for prescription drugs in 2011. The Chinese pharma market could grow by 100% by 2013 as the country upgrades health-care infrastructure and takes care to provide universal coverage. Pharma sales revenues in China will grow by US$40 billion by 2013, at par with sales growth forecast for the U.S. during the same time.

The second tier of rapidly growing pharma emerging markets include three countries viz. Brazil, Russia and India each of whom is predicted to add $5 billion to $15 billion in sales over the next three years. Brazil will be buying more medications than Britain and will become the world's eighth-largest pharma market by next year.

The third tier of emerging markets contain names of thirteen countries including Venezuela, Argentina, Turkey, Mexico, Indonesia, and Vietnam, among others. Each of these countries is expected to see $1 billion to $5 billion growth.

The top pharmaceutical companies worldwide, already aware of the growth of these emerging markets, are making serious efforts to target these markets. Many large multinationals have announced acquisitions in recent years and many others have started joint ventures with local manufacturers of these growing pharma markets.

News Source: NASDAQ